Key Points GAAP revenue of $37.2 million missed expectations by 2.3% in Q2 2025. Acute Care segment revenue surged 55.5%, while Oncology segment revenue declined 9.0%. Full-year 2025 adjusted EBITDA ...

However, non-GAAP financials are still governed by the SEC. In fact, the SEC has taken action in the past against companies that it believes are being too aggressive with non-GAAP numbers.

However, non-GAAP financials are still governed by the SEC. In fact, the SEC has taken action in the past against companies that it believes are being too aggressive with non-GAAP numbers.

WM Technology, Inc. (NASDAQ: MAPS) Q2 2025 Earnings Call Transcript August 7, 2025 WM Technology, Inc. misses on earnings ...

Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

Discover CompoSecure's Q2 2025 earning highlights: strong revenue growth, margin gains, raised guidance, and expansion of metal card & ...

Reports Q2 revenue $176.5M, consensus $168.97M. “Our second quarter results were strong, exceeding the high end of our outlook for both revenue ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

Reports Q2 revenue $973M, consensus $932.42M. “We delivered revenue and adjusted EBITDA above the high end of our guidance, driven by strong year ...

Consequently, DXC “negligently failed to evaluate the company’s non-GAAP disclosures adequately.” DXC agreed to pay a civil penalty of $8 million. (See this PubCo post.) ...

Backblaze just two quarters ago turned cash-flow-positive and expects to become GAAP net-income-positive within a few years, ...